Pre-Market Surge In OncoCyte (OCX) Stock After Unveiling Financials
The current ascent of OncoCyte Corporation (NASDAQ: OCX) has attracted attention, with a notable 13.32% increase to $3.40 observed during the latest pre-market trading session. This uptick in OCX stock value coincides with the unveiling of its financial performance. OncoCyte (OCX) disclosed its financial outcomes for the fiscal year concluding on December 31, 2023. Total […]